The Future of Precision Cancer Care is Here.
What We DoEliminating Uncertainty, Individualizing Care
At SimBioSys, we are determined to deliver on the promise of precision cancer care by combining the power of science and software into a first-of-its kind biophysical simulation technology to:
- Give physicians the ability to better predict response to therapy during treatment planning to individualize treatment selection, enabling improvement in outcomes while lowering toxicity for patients
- Provide patients and physicians with a platform for shared decision making and collaboration, transforming patient experience
- Identify novel and actionable insights capturing the impact of drug delivery, metabolism, spatial heterogeneity and physical traits, expediting the drug development process
Our Solutions
For Clinicians
To empower clinicians with individualized treatment planning tools
For Life Sciences
To arm drug developers with novel biomarkers, patient stratification, clinical trial selection and design strategies
News and Resources
SimBioSys Presents 9 Applications of TumorScope Platform at AACR 2022
Genoa Ventures and Northpond Ventures co-lead investment in precision medicine platform that develops virtual tumors in 3D to predict response to therapy using standard-of-care data
Biopharma Dealmakers: Virtualizing cancer to eliminate uncertainty and individualize care
No two tumors are alike. What if we could model treatment planning for each individual patient? Meet TumorScope – the first of its kind 4D Tumor Modeling platform that combines state of the art biophysical...
Novel Device May Predict Response to Therapy in Patients With Early Breast Cancer
Frederick Howard, MD, a medical oncology fellow in the Department of Medicine at the University of Chicago, discussed the clinical benefits of the SimBioSys TumorScope model for the treatment of early breast...
SimBioSys Raises $15 Million Series A to Develop the Future of Precision Cancer Care
Genoa Ventures and Northpond Ventures co-lead investment in precision medicine platform that develops virtual tumors in 3D to predict response to therapy using standard-of-care data
Highlights from ESMO Breast Cancer 2022
By Dorys Lopez The ESMO Breast Cancer 2022 took place in Berlin on May 3 – 5. A well-attended conference covering a broad range of breast cancer topics. Our team was there to present three posters. Here are...
Highlights from AACR2022
By Dorys LopezAfter two consecutive years of virtually holding the annual meeting of the American Association for Cancer Research (AACR), the conference returned to an in-person format, while retaining a...
Key take home messages from the San Antonio Breast Cancer Symposium 2021
By Dorys Lopez From December 7th -10th the San Antonio Breast Cancer Symposium gathered breast cancer experts from all over the world to share the latest medical and scientific advances in the breast cancer...
Why is it important to raise breast cancer awareness?
By Dorys Lopez Breast cancer is a group of diseases, each one characterized by different molecular features, and each one with different treatment needs. Scientific advances in the field of precision medicine...